Image

A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

Study on symptom changes in advanced Parkinson's using a new treatment in Belgium.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Parkinson's Disease (PD) is a brain disorder that worsens over time and can cause tremors, stiffness, and slow movements. This study in Belgium aims to see how well a drug called Foslevodopa/Foscarbidopa helps adults with advanced PD. This drug is already approved for PD treatment. Around 120 adults will be part of this study across 15 sites in Belgium. They will receive the drug through a tube under the skin, as their doctor prescribes. The study will last up to 18 months, but participants will just follow their usual hospital or clinic visits, so there's no extra burden.

  • Length: The study follows participants for up to 18 months.
  • Visits: Regular hospital or clinic visits as part of routine care.
  • Participation: No extra burden; just follow your doctor's instructions.
    • Print
    Study details
      Parkinson's Disease

    NCT07382440

    AbbVie

    17 April 2026

    Contact a study center
    Step 1 Get in touch with the nearest study center
    We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
    Would you like to be notified about other trials? Sign up for Patient Notification Services.
    Sign up

    Send a message

    Enter your contact details to connect with study team

    Email

    View email

    Phone

    Phone country flag

    View phone
    Investigator Avatar

    Primary Contact

      Other languages supported:

    First name*
    Last name*
    Email*
    Phone number*
    Other language

    FAQs

    Learn more about clinical trials

    What is a clinical trial?

    A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

    Why should I take part in a clinical trial?

    Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

    How long does a clinical trial take place?

    The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

    Do I get compensated for taking part in clinical trials?

    Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

    How safe are clinical trials?

    Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
    Add a private note
    • abc Select a piece of text.
    • Add notes visible only to you.
    • Send it to people through a passcode protected link.